Reply to comment on “Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter”
-
Published:2023
Issue:
Volume:122
Page:S103-S104
-
ISSN:0929-6646
-
Container-title:Journal of the Formosan Medical Association
-
language:en
-
Short-container-title:Journal of the Formosan Medical Association
Author:
Tai Ta-Wei,
Wu Chih-HsingORCID